良性指征子宫切除术后基于抗生素预防方案的尿路感染风险
基于Premier医疗数据库2000年1月至2022年12月220,499例良性指征子宫切除术患者的回顾性队列研究,比较三种预防性抗生素方案与术后尿路感染风险。接受庆大霉素+克林霉素者较头孢唑林或头孢唑林+甲硝唑者术后尿路感染风险升高,而头孢唑林与头孢唑林+甲硝唑之间无显著差异。
要点
- 84.6%患者接受头孢唑林单药,8.2%接受头孢唑林+甲硝唑,7.2%接受庆大霉素+克林霉素。
- 术后尿路感染总体发生率为3.2%。
- 庆大霉素+克林霉素较头孢唑林(HR 1.36,95%CI 1.26-1.47)及头孢唑林+甲硝唑(HR 1.34,95%CI 1.20-1.50)尿路感染风险升高。
核心结论
- 良性指征子宫切除术时接受庆大霉素+克林霉素预防者,术后尿路感染风险高于接受头孢唑林或头孢唑林+甲硝唑者。
研究设计与样本
- 回顾性队列研究,数据来自Premier医疗数据库,纳入2000年1月至2022年12月间220,499例良性指征子宫切除术患者。
主要发现
- 84.6%患者接受头孢唑林单药,8.2%接受头孢唑林+甲硝唑,7.2%接受庆大霉素+克林霉素。
- 术后尿路感染总体发生率为3.2%。
- 逆概率加权后,庆大霉素+克林霉素较头孢唑林术后尿路感染风险升高(HR 1.36,95%CI 1.26-1.47)。
- 庆大霉素+克林霉素较头孢唑林+甲硝唑术后尿路感染风险升高(HR 1.34,95%CI 1.20-1.50)。
- 头孢唑林与头孢唑林+甲硝唑相比风险无显著差异(HR 1.02,95%CI 0.93-1.11)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the rate of postoperative urinary tract infection (UTI) after hysterectomy based on antibiotic prophylaxis regimen. DESIGN: Retrospective cohort study SETTING: Premier Healthcare Database PARTICIPANTS: A total of 220,499 patients undergoing hysterectomy for benign indications between January 2000 and December 2022 were included. Patients were excluded if they received any antibiotic regimen other than the prespecified prophylaxis groupings, no antibiotic prophylaxis was documented or if a prolapse or anti-incontinence procedure was performed. INTERVENTIONS: Patients were grouped by those who received cefazolin, cefazolin + metronidazole, or gentamicin + clindamycin for perioperative antibiotic prophylaxis. RESULTS: Of the included patients, 84.6% received cefazolin alone, 8.2% received cefazolin + metronidazole and 7.2% received gentamicin + clindamycin. The overall rate of postoperative UTI was 3.2%. After performing inverse probability of treatment weighted analysis based on preoperative and operative characteristics, the hazard ratio for developing a postoperative UTI suggests an increased risk for those receiving gentamicin + clindamycin compared to those receiving cefazolin (HR 1.36, 95% CI [1.26-1.47]) or cefazolin + metronidazole (HR 1.34, 95% CI [1.20-1.50]). The HR for those receiving cefazolin compared with cefazolin + metronidazole was not significantly different from 1 (HR 1.02, 95% CI [0.93-1.11]). Cumulative incidence, after weighting, demonstrated that those who received gentamicin + clindamycin were more likely to have a readmission or emergency department visit for a UTI related diagnosis within three months after surgery than those who received cefazolin or cefazolin + metronidazole. CONCLUSION: Patients who receive gentamicin + clindamycin at the time of hysterectomy for benign indications are more likely to experience a postoperative UTI than those who receive cefazolin or cefazolin + metronidazole.
引用
- Bauer HH, Villarreal EM, Rhodes SP, et al. Risk of Urinary Tract Infection After Hysterectomy for Benign Indications Based on Antibiotic Prophylaxis Regimen. J Minim Invasive Gynecol. 2025. PMID: 41061893. doi:10.1016/j.jmig.2025.09.527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。